Navigation Links
Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
Date:9/26/2007

r a further list and description of such risks and uncertainties that could cause the actual results, performance or achievements of the Company to be materially different from any anticipated results, performance or achievements, please see the Company's previously filed SEC reports. Spectranetics disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether as a result of new information, future events or otherwise.

COMPANY CONTACT: INVESTOR RELATIONS CONTACTS

Spectranetics Corporation Lippert/Heilshorn & Associates, Inc.

Guy Childs, Chief Financial Officer Bruce Voss/Don Markley

(719) 633-8333 (310) 691-7100

http://www.spectranetics.com http://www.lhai.com

MEDIA RELATIONS CONTACT:

Schwartz Communications, Inc.

Stacey Holifield

(781) 684-0770

spectranetics@schwartz-pr.com


'/>"/>
SOURCE Spectranetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Companies, Inc. (ICBU) has repositioned itself as a holding company ... foothold in the hydroponic, hemp and medical marijuana sectors. By ... the sector, and recently partnering with the Chippewa Tribe Nation ... marijuana, iMD is committing to bring its vision to the ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... CHENGDU, China , Jan. 23, 2015 Tianyin ... pharmaceutical company that specializes in the development and sale ... branded generics and active pharmaceutical ingredients (API) today announced ... Facility (JCM) API operation. 1. Following the ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... RICHMOND, Calif., Oct. 29 Transcept Pharmaceuticals (Nasdaq: ... Drug Administration (FDA) issued a Complete Response Letter regarding ... (zolpidem tartrate sublingual tablet). The NDA, submitted by ... Intermezzo® for use as-needed for the treatment of ...
... Corporation, makers of Praxis Electronic Medical Records (EMR), announced ... Datum, a tool that allows physicians to use free ... The Praxis Datum engine guarantees full qualification for Federal ... use, guidelines. , With Federal stimulus funds under the ...
Cached Medicine Technology:Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application 2Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application 3Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application 4Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application 5Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 2
(Date:1/22/2015)... Hollywood, California (PRWEB) January 22, 2015 The City ... 2015 at 10 a.m., to commemorate the 42nd anniversary of the ... United States. , “It’s been 42 years since the Roe vs. ... choose is still as present as ever,” said City of West ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Padre Murphy's and ... supporter of Pro Player Health Alliance (PPHA). The ... Murphy's in getting everyone, including NFL greats, treated for obstructive ... the leading groups supporting the cause in the valley. The ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... dangerous atrial fibrillation , , WEDNESDAY, Sept. 5 (HealthDay News) -- ... abnormal heartbeat called atrial fibrillation. , The drug, dronedarone, is ... but has proven effective in two major trials, with fewer ... the Sept. 6 issue of the New England Journal ...
... Discoveries could lead to new treatments for autoimmune diseases, scientists ... boost the risk of painful rheumatoid arthritis, and one of ... new reports. , In one report, a variant of the ... genes now identified to increase the risk of developing rheumatoid ...
... have an East Valley location, CHANDLER, Ariz., Sept. 5 ... Village Health Club and Spa will,be built, this one in ... the land at the corner of Alma School and,Ocotillo Road ... The,purchase of the 7.3 acres in this growing part of ...
... Sept. 5 With only days,remaining in the 2007 ... Arnold Schwarzenegger, as well as state legislative,leaders, are awaiting ... health care coverage and the quality of care., ... about how AARP,members feel about the need for health ...
... is largest by an individual to a children,s hospital ... announced,today that philanthropist Ann Lurie has pledged $100 million ... Hospital in Chicago. This,gift is the largest given by ... The $100 million gift, the largest charitable investment ...
... Addresses the National Need for More Nurse Educators, ... Colleges of Nursing (AACN) is pleased to announce ... (J&J) is launching a new national,scholarship program designed ... minority backgrounds. The J&J-AACN Minority Nurse Faculty Scholars,program ...
Cached Medicine News:Health News:Drug, Pacemaker Fight Irregular Heartbeat 2Health News:Drug, Pacemaker Fight Irregular Heartbeat 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:Ocotillo in Chandler Will Have a Village 2Health News:AARP Poll: California Members Want Health Care Reform THIS YEAR 2Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 2Health News:Children's Memorial Hospital in Chicago Announces $100 Million Gift from Philanthropist Ann Lurie 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 2Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 4
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
Medicine Products: